{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:28:42Z","timestamp":1772166522844,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology","award":["22390284"],"award-info":[{"award-number":["22390284"]}]},{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology","award":["22-40134"],"award-info":[{"award-number":["22-40134"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multipotent mesenchymal stromal cells (MSCs) are potentially therapeutic for muscle disease because they can accumulate at the sites of injury and act as immunosuppressants. MSCs are attractive candidates for cell-based strategies that target diseases with chronic inflammation, such as Duchenne muscular disease (DMD). We focused on the anti-inflammatory properties of IL-10 and hypothesized that IL-10 could increase the typically low survival of MSCs by exerting a paracrine effect after transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We developed a continuous IL-10 expression system of MSCs using an adeno-associated virus (AAV) vector. To investigate the potential benefits of IL-10 expressing AAV vector-transduced MSCs (IL-10-MSCs), we examined the cell survival rates in the skeletal muscles after intramuscular injection into mice and dogs. Systemic treatment with IL-10-MSCs derived from dental pulp (DPSCs) was comprehensively analyzed using the canine X-linked muscular dystrophy model in Japan (CXMD\n                      <jats:sub>J<\/jats:sub>\n                      ), which has a severe phenotype similar to that of DMD patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In vivo bioluminescence imaging analysis revealed higher retention of IL-10-MSCs injected into the hindlimb muscle of mice. In the muscles of dogs, myofiber-like tissue was formed after the stable engraftment of IL-10-MSCs. Repeated systemic administration of IL-10-DPSCs into the CXMD\n                      <jats:sub>J<\/jats:sub>\n                      model resulted in long-term engraftment of cells and slightly increased the serum levels of IL-10. IL-10-hDPSCs showed significantly reduced expression of pro-inflammatory MCP-1 and upregulation of stromal-derived factor-1 (SDF-1). MRI and histopathology of the hDPSC-treated CXMD\n                      <jats:sub>J<\/jats:sub>\n                      indicated the regulation of inflammation in the muscles, but not myogenic differentiation from treated cells. hDPSC-treated CXMD\n                      <jats:sub>J<\/jats:sub>\n                      showed improved running capability and recovery in tetanic force with concomitant increase in physical activity. Serum creatine kinase levels, which increased immediately after exercise, were suppressed in IL-10-hDPSC-treated CXMD\n                      <jats:sub>J<\/jats:sub>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In case of local injection, IL-10-MSCs could maintain the long-term engraftment status and facilitate associated tissue repair. In case of repeated systemic administration, IL-10-MSCs facilitated the long-term retention of the cells in the skeletal muscle and also protected muscles from physical damage-induced injury, which improved muscle dysfunction in DMD. We can conclude that the local and systemic administration of IL-10-producing MSCs offers potential benefits for DMD therapy through the beneficial paracrine effects of IL-10 involving SDF-1.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-021-02168-1","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T07:06:13Z","timestamp":1612422373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy"],"prefix":"10.1186","volume":"12","author":[{"given":"Yuko","family":"Nitahara-Kasahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuki","family":"Kuraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Hayashita-Kinoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin\u2019ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2910-3797","authenticated-orcid":false,"given":"Takashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"2168_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","volume":"6","author":"AJ Friedenstein","year":"1968","unstructured":"Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230\u201347.","journal-title":"Transplantation."},{"key":"2168_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F","volume":"64","author":"SP Bruder","year":"1997","unstructured":"Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem. 1997;64:278\u201394.","journal-title":"J Cell Biochem"},{"key":"2168_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/8756-3282(92)90364-3","volume":"13","author":"SE Haynesworth","year":"1992","unstructured":"Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone. 1992;13:81\u20138.","journal-title":"Bone."},{"key":"2168_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1126\/science.1110364","volume":"309","author":"M Dezawa","year":"2005","unstructured":"Dezawa M, Ishikawa H, Itokazu Y, Yoshihara T, Hoshino M, Takeda S, Ide C, Nabeshima Y. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science. 2005;309:314\u20137.","journal-title":"Science."},{"key":"2168_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.intimp.2005.09.015","volume":"6","author":"Y Sun","year":"2006","unstructured":"Sun Y, Liu J, Qian F, Xu Q. Nitric oxide inhibits T cell adhesion and migration by down-regulation of beta1-integrin expression in immunologically liver-injured mice. Int Immunopharmacol. 2006;6:616\u201326.","journal-title":"Int Immunopharmacol"},{"key":"2168_CR6","doi-asserted-by":"publisher","first-page":"10711","DOI":"10.1073\/pnas.96.19.10711","volume":"96","author":"GC Kopen","year":"1999","unstructured":"Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A. 1999;96:10711\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2168_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1634\/stemcells.2005-0046","volume":"24","author":"Y Ma","year":"2006","unstructured":"Ma Y, Xu Y, Xiao Z, Yang W, Zhang C, Song E, Du Y, Li L. Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells. 2006;24:315\u201321.","journal-title":"Stem Cells"},{"key":"2168_CR8","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499\u2013506.","journal-title":"Blood."},{"key":"2168_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","volume":"76","author":"I Rasmusson","year":"2003","unstructured":"Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation. 2003;76:1208\u201313.","journal-title":"Transplantation."},{"key":"2168_CR10","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E Zappia","year":"2005","unstructured":"Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood. 2005;106:1755\u201361.","journal-title":"Blood."},{"key":"2168_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cellimm.2009.10.006","volume":"260","author":"TE Ichim","year":"2010","unstructured":"Ichim TE, Alexandrescu DT, Solano F, Lara F, Campion Rde N, Paris E, Woods EJ, Murphy MP, Dasanu CA, Patel AN, Marleau AM, Leal A, Riordan NH. Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol. 2010;260:75\u201382.","journal-title":"Cell Immunol"},{"key":"2168_CR12","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815\u201322.","journal-title":"Blood."},{"key":"2168_CR13","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.4049\/jimmunol.163.10.5599","volume":"163","author":"KP MacDonald","year":"1999","unstructured":"MacDonald KP, Pettit AR, Quinn C, Thomas GJ, Thomas R. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10. J Immunol. 1999;163:5599\u2013607.","journal-title":"J Immunol"},{"key":"2168_CR14","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.4049\/jimmunol.160.7.3188","volume":"160","author":"H Groux","year":"1998","unstructured":"Groux H, Bigler M, de Vries JE, Roncarolo MG. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol. 1998;160:3188\u201393.","journal-title":"J Immunol"},{"key":"2168_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1089\/hum.2009.147","volume":"21","author":"E Manning","year":"2010","unstructured":"Manning E, Pham S, Li S, Vazquez-Padron RI, Mathew J, Ruiz P, Salgar SK. Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum Gene Ther. 2010;21:713\u201327.","journal-title":"Hum Gene Ther"},{"key":"2168_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.bmt.1705644","volume":"39","author":"CK Min","year":"2007","unstructured":"Min CK, Kim BG, Park G, Cho B, Oh IH. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;39:637\u201345.","journal-title":"Bone Marrow Transplant"},{"key":"2168_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12974-018-1383-2","volume":"16","author":"ST Peruzzaro","year":"2019","unstructured":"Peruzzaro ST, Andrews MMM, Al-Gharaibeh A, Pupiec O, Resk M, Story D, Maiti P, Rossignol J, Dunbar GL. Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury. J Neuroinflammation. 2019;16:2.","journal-title":"J Neuroinflammation"},{"key":"2168_CR18","doi-asserted-by":"publisher","first-page":"8446","DOI":"10.7150\/thno.31711","volume":"10","author":"X Lu","year":"2020","unstructured":"Lu X, Ru Y, Chu C, Lv Y, Gao Y, Jia Z, Huang Y, Zhang Y, Zhao S. Lentivirus-mediated IL-10-expressing bone marrow mesenchymal stem cells promote corneal allograft survival via upregulating lncRNA 003946 in a rat model of corneal allograft rejection. Theranostics. 2020;10:8446\u201367.","journal-title":"Theranostics."},{"key":"2168_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.33594\/000000051","volume":"52","author":"D Meng","year":"2019","unstructured":"Meng D, Han S, Jeong IS, Kim SW. Interleukin 10-secreting MSCs via TALEN-mediated gene editing attenuates left ventricular remodeling after myocardial infarction. Cell Physiol Biochem. 2019;52:728\u201341.","journal-title":"Cell Physiol Biochem"},{"key":"2168_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2249.2008.03683.x","volume":"153","author":"JJ Choi","year":"2008","unstructured":"Choi JJ, Yoo SA, Park SJ, Kang YJ, Kim WU, Oh IH, Cho CS. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol. 2008;153:269\u201376.","journal-title":"Clin Exp Immunol"},{"key":"2168_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/dna.2017.3735","volume":"37","author":"C Wang","year":"2018","unstructured":"Wang C, Lv D, Zhang X, Ni ZA, Sun X, Zhu C. Interleukin-10-overexpressing mesenchymal stromal cells induce a series of regulatory effects in the inflammatory system and promote the survival of endotoxin-induced acute lung injury in mice model. DNA Cell Biol. 2018;37:53\u201361.","journal-title":"DNA Cell Biol"},{"key":"2168_CR22","first-page":"145","volume":"24","author":"Y Shimatsu","year":"2005","unstructured":"Shimatsu Y, Yoshimura M, Yuasa K, Urasawa N, Tomohiro M, Nakura M, Tanigawa M, Nakamura A, Takeda S. Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ. Acta Myol. 2005;24:145\u201354.","journal-title":"Acta Myol"},{"key":"2168_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1538\/expanim.52.93","volume":"52","author":"Y Shimatsu","year":"2003","unstructured":"Shimatsu Y, Katagiri K, Furuta T, Nakura M, Tanioka Y, Yuasa K, Tomohiro M, Kornegay JN, Nonaka I, Takeda S. Canine X-linked muscular dystrophy in Japan (CXMDJ). Exp Anim. 2003;52:93\u20137.","journal-title":"Exp Anim"},{"key":"2168_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1089\/ten.2006.0192","volume":"13","author":"YY Jo","year":"2007","unstructured":"Jo YY, Lee HJ, Kook SY, Choung HW, Park JY, Chung JH, Choung YH, Kim ES, Yang HC, Choung PH. Isolation and characterization of postnatal stem cells from human dental tissues. Tissue Eng. 2007;13:767\u201373.","journal-title":"Tissue Eng"},{"key":"2168_CR25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.biopha.2018.09.084","volume":"108","author":"C Nito","year":"2018","unstructured":"Nito C, Sowa K, Nakajima M, Sakamoto Y, Suda S, Nishiyama Y, Nakamura-Takahashi A, Nitahara-Kasahara Y, Ueda M, Okada T, Kimura K. Transplantation of human dental pulp stem cells ameliorates brain damage following acute cerebral ischemia. Biomed Pharmacother. 2018;108:1005\u201314.","journal-title":"Biomed Pharmacother"},{"key":"2168_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jgm.1313","volume":"11","author":"R Uchibori","year":"2009","unstructured":"Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A, Ozawa K. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy. J Gene Med. 2009;11:373\u201381.","journal-title":"J Gene Med"},{"key":"2168_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/mt.2011.181","volume":"20","author":"Y Nitahara-Kasahara","year":"2012","unstructured":"Nitahara-Kasahara Y, Hayashita-Kinoh H, Ohshima-Hosoyama S, Okada H, Wada-Maeda M, Nakamura A, Okada T, Takeda S. Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy. Mol Ther. 2012;20:168\u201377.","journal-title":"Mol Ther"},{"key":"2168_CR28","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1093\/hmg\/ddu113","volume":"23","author":"Y Nitahara-Kasahara","year":"2014","unstructured":"Nitahara-Kasahara Y, Hayashita-Kinoh H, Chiyo T, Nishiyama A, Okada H, Takeda S, Okada T. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10. Hum Mol Genet. 2014;23:3990\u20134000.","journal-title":"Hum Mol Genet"},{"key":"2168_CR29","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1089\/hum.2005.16.1212","volume":"16","author":"T Okada","year":"2005","unstructured":"Okada T, Nomoto T, Yoshioka T, Nonaka-Sarukawa M, Ito T, Ogura T, Iwata-Okada M, Uchibori R, Shimazaki K, Mizukami H, Kume A, Ozawa K. Large-scale production of recombinant viruses by use of a large culture vessel with active gassing. Hum Gene Ther. 2005;16:1212\u20138.","journal-title":"Hum Gene Ther"},{"key":"2168_CR30","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1089\/hum.2009.006","volume":"20","author":"T Okada","year":"2009","unstructured":"Okada T, Nonaka-Sarukawa M, Uchibori R, Kinoshita K, Hayashita-Kinoh H, Nitahara-Kasahara Y, Takeda S, Ozawa K. Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes. Hum Gene Ther. 2009;20:1013\u201321.","journal-title":"Hum Gene Ther"},{"key":"2168_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/mt.2015.5","volume":"23","author":"H Hayashita-Kinoh","year":"2015","unstructured":"Hayashita-Kinoh H, Yugeta N, Okada H, Nitahara-Kasahara Y, Chiyo T, Okada T, Takeda S. Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance. Mol Ther. 2015;23:627\u201337.","journal-title":"Mol Ther"},{"key":"2168_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/mus.21384","volume":"40","author":"M Kobayashi","year":"2009","unstructured":"Kobayashi M, Nakamura A, Hasegawa D, Fujita M, Orima H, Takeda S. Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging. Muscle Nerve. 2009;40:815\u201326.","journal-title":"Muscle Nerve"},{"key":"2168_CR33","doi-asserted-by":"publisher","first-page":"e0208415","DOI":"10.1371\/journal.pone.0208415","volume":"13","author":"M Kuraoka","year":"2018","unstructured":"Kuraoka M, Nitahara-Kasahara Y, Tachimori H, Kato N, Shibasaki H, Shin A, Aoki Y, Kimura E, Takeda S. Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs. Plos One. 2018;13:e0208415.","journal-title":"Plos One"},{"key":"2168_CR34","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1073\/pnas.87.20.7988","volume":"87","author":"J Choi","year":"1990","unstructured":"Choi J, Costa ML, Mermelstein CS, Chagas C, Holtzer S, Holtzer H. MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc Natl Acad Sci U S A. 1990;87:7988\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2168_CR35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/sj.cr.7310116","volume":"16","author":"B Balana","year":"2006","unstructured":"Balana B, Nicoletti C, Zahanich I, Graf EM, Christ T, Boxberger S, Ravens U. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res. 2006;16:949\u201360.","journal-title":"Cell Res"},{"key":"2168_CR36","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1038\/ncomms5063","volume":"5","author":"P Huang","year":"2014","unstructured":"Huang P, Schulz TJ, Beauvais A, Tseng YH, Gussoni E. Intramuscular adipogenesis is inhibited by myo-endothelial progenitors with functioning Bmpr1a signalling. Nat Commun. 2014;5:4063.","journal-title":"Nat Commun"},{"key":"2168_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/cells9010078","volume":"9","author":"S Sasse","year":"2019","unstructured":"Sasse S, Skorska A, Lux CA, Steinhoff G, David R, Gaebel R. Angiogenic potential of bone marrow derived CD133(+) and CD271(+) intramyocardial stem cell trans- plantation post MI. Cells. 2019;9:78\u201394.","journal-title":"Cells."},{"key":"2168_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2174\/1574888X11666160614102629","volume":"11","author":"Q Luo","year":"2016","unstructured":"Luo Q, Zhang B, Kuang D, Song G. Role of stromal-derived factor-1 in mesenchymal stem cell paracrine-mediated tissue repair. Curr Stem Cell Res Ther. 2016;11:585\u201392.","journal-title":"Curr Stem Cell Res Ther"},{"key":"2168_CR39","doi-asserted-by":"publisher","first-page":"e34608","DOI":"10.1371\/journal.pone.0034608","volume":"7","author":"H Liu","year":"2012","unstructured":"Liu H, Liu S, Li Y, Wang X, Xue W, Ge G, Luo X. The role of SDF-1-CXCR4\/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia\/reperfusion injury. Plos One. 2012;7:e34608.","journal-title":"Plos One"},{"key":"2168_CR40","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.yexcr.2012.06.020","volume":"318","author":"C Hunger","year":"2012","unstructured":"Hunger C, Odemis V, Engele J. Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration. Exp Cell Res. 2012;318:2178\u201390.","journal-title":"Exp Cell Res"},{"key":"2168_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41232-016-0019-0","volume":"36","author":"Y Nitahara-Kasahara","year":"2016","unstructured":"Nitahara-Kasahara Y, Takeda S, Okada T. Inflammatory predisposition predicts disease phenotypes in muscular dystrophy. Inflamm Regen. 2016;36:14.","journal-title":"Inflamm Regen"},{"key":"2168_CR42","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/BF00869001","volume":"243","author":"SC Jacobs","year":"1996","unstructured":"Jacobs SC, Bootsma AL, Willems PW, Bar PR, Wokke JH. Prednisone can protect against exercise-induced muscle damage. J Neurol. 1996;243:410\u20136.","journal-title":"J Neurol"},{"key":"2168_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/mus.23432","volume":"46","author":"F Serra","year":"2012","unstructured":"Serra F, Quarta M, Canato M, Toniolo L, De Arcangelis V, Trotta A, Spath L, Monaco L, Reggiani C, Naro F. Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs. Muscle Nerve. 2012;46:773\u201384.","journal-title":"Muscle Nerve"},{"key":"2168_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.omtm.2017.06.005","volume":"6","author":"M Nakajima","year":"2017","unstructured":"Nakajima M, Nito C, Sowa K, Suda S, Nishiyama Y, Nakamura-Takahashi A, Nitahara-Kasahara Y, Imagawa K, Hirato T, Ueda M, Kimura K, Okada T. Mesenchymal stem cells overexpressing interleukin-10 promote neuroprotection in experimental acute ischemic stroke. Mol Ther Methods Clin Dev. 2017;6:102\u201311.","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-021-02168-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:21:37Z","timestamp":1697775697000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02168-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2168"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02168-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-73149\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-73149\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-73149\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"8 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments using MSCs were conducted in accordance with the protocol approved by the Institutional Animal Care and Use Committee of Nippon Medical School (27-199) and National Center of Neurology and Psychiatry (NCNP) Animal Ethics Committees (2012011, 2015004, and 19\u201330-06).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Y. N-K., H. H-K., and T. O. were members of the Division of Cell and Gene Therapy, Nippon Medical School, which is an endowment department, supported with an unrestricted grant from JCR Pharmaceuticals Co., Ltd. and Kaneka Corporation. hDPSCs were provided by JCR Pharmaceuticals Co., Ltd. There is no COI related to other authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}